Published: Saturday June 23, 2012 MYT 12:22:00 PM
Google CEO says "nothing seriously wrong" - source
SAN FRANCISCO: Google Inc
Page sat out his company's annual shareholders' meeting on Thursday. The 39-year-old Google co-founder is resting his voice because of an unspecified condition, and he will miss Google's annual developer conference next week as well as its quarterly results announcement next month, executives said on Thursday without elaborating.
Page continues to run Google's business, Executive Chairman Eric Schmidt told attendees at the shareholder meeting on Thursday. But Page's prolonged absence from the public spotlight raises questions about his condition, and the company's obligation to highlight issues of concern to shareholders.
Corporate governance experts say Google has met minimal disclosure requirements but will face increasing pressure while Page remains out of sight.
On Friday, Google's shares rose 1.1 percent to $571.48, lifted along with the rest of the Nasdaq.
"It gets them over the first disclosure hurdle, that is they've alerted shareholders to the fact he's going to have this health effect," said James Post, a professor of management at Boston University who focuses on corporate governance issues.
"It's OK for them not to say that. As more information emerges from other sources, the tough questions still lie ahead, and there will be continued pressure to keep answering those tough questions."
Google would not comment on its CEO's medical condition on Friday.
Page, co-founder Sergey Brin and Schmidt control a majority of the Internet company through special shares that give them more voting power.
That capital structure, emulated by a new generation of Web companies from Facebook Inc
Wall Street analysts mostly took the news of Page's extended absence in stride, though some expressed concern about the lack of information.
"It's the number one thing I'm concerned about today just because there's so little data available," said BGC Partners analyst Colin Gillis.
JP Morgan analyst Doug Anmuth noted that Page has not posted any messages to his Google+ profile since May 25.
"We have no specific reason to think there is anything more to Larry's condition, but we find it odd that the company would already rule him out of the 2Q call, which is likely still a few weeks away," Anmuth wrote to clients late on Thursday.
"This could raise some questions among investors."
Simon Best, a head and neck surgery specialist at the Johns Hopkins Voice Center, said most cases where doctor might order a patient to rest their voice involved either a vocal chord hemorrhage or bleeding, or throat surgery of some sort.
"We actually very rarely put people on complete voice rest where they are not cleared to talk or allowed to talk," West said. "There are probably some practice differences between physicians and whoever is treating him, but there are only two scenarios where we put people on voice rest: if they've had vocal cord surgery, or if they've had a vocal chord hemorrhage."
Best, who has not treated Page, said hemorrhages were easily treatable, but a wide variety of conditions might necessitate surgery.
The Wall Street Journal first reported on the details of Page's internal memo on Friday. - Reuters
- Pakatan to file 27 election petitions, says Tian Chua
- Transport Ministry reveals new FT registration plate to start with W1A
- Ahmad Zahid: Government will take action on foreigners who abuse student visas
- Adam Adli claims trial to sedition charge
- Tian Chua, Haris Ibrahim, Tamrin Ghafar detained (Update)
- Tabung Haji top-level official denies khalwat
- Justice Akhtar: Intention to finish off Sosilawati, others at wrong place wrong time
- Verdict ends three years of restlessness for family, says Sosilawati's daughter
- Adam Adli charged with uttering seditious words (Update)
- All four accused guilty in murder of Sosilawati Lawiya and three others (Update)
- New crime prevention department to be set up

- Syariah Court can annul child’s marriage, says SIS
- A-G: Prosecution to proceed with statutory rape charges against Riduan
- Women’s groups laud A-G’s promise to press statutory rape charges against Riduan
- Probe into why teen withdrew rape report
- Japan stocks crash on volatile bonds, weak China data; Nikkei ends down 7.3%
- MISC posts RM300m net profit in Q1, sees challenging year ahead
- KL Kepong slips to low of RM21.36 as quarterly profit drops
- Maybank's Q1 earnings up 11.8% to RM1.506b
- Lafarge Cement positive on markets, mulls expanding capacity
- Dayang Enterprise awards RM705m contract to Perdana Petroleum
- KLCI pauses, Japan, Hong Kong key indices slide (Update)
- ECM Libra plans to exit PN17 by year-end
- China HSBC flash PMI hits 7-mth low, fans growth fears
- RHB Research maintains Buy on KPJ Healthcare, FV RM7.30
- Alliance Neutral on Axiata, ups target price to RM7
- Deleum top loser, down 11.3% after disappointing results
- Maybank KE Research maintains Hold on AirAsia
- Public Invest Research ups Uzma target price to RM2.86
- Malaysia's blue chips fall more than 6pts in early trade
- Ice queen Nicol into British Open quarters
- Australia to consider following ban on anchor putters
- Intxausti wins 16th stage, Nibali still keeps pink jersey
- Indonesia drawn to meet China again – in knockout stage
- Results worldwide
- Malacca sprinter Mohd Azam Masri out to create history by winning five events in MSSM meet
- Athletics runs in the veins of Vallabouy family
- Chinese long jumper Jinzhe claims another Olympic scalp
- Dane Jorgensen’s wish is to avoid Chinese ace Lin Dan in World Championships
- National badminton team’s lack of depth a glaring factor in home tourney
- Khim Wah-V Shem perform above expectations in Sudirman Cup debut
- Jindapon aims to qualify for 2016 Olympics
- Kenichi’s goal is to take Japan into Sudirman Cup semi-finals
- Dong-keun shows he’s a capable replacement
- Harrison makes swift U-turn
- Aeon director: GST won’t affect group
- Malaysia's blue chips fall more than 6pts in early trade
- Petronas Chemicals Group to invest RM3bil in capital expenditure
- Report: AirAsia X sets indicative price for IPO
- Profit taking may weigh on Malaysian equities
- Lower net profit for AirAsia
- BToto buys RM20m REDtone shares
- Weak CPO prices hit Boustead profit
- No plans for MBO, says Vincent Lee
- Deleum top loser, down 11.3% after disappointing results
- Petronas Chemicals Group to invest RM3bil in capital expenditure
- Maybank's Q1 earnings up 11.8% to RM1.506b
- Asean flavour in Invest M’sia confab
- Report: AirAsia X sets indicative price for IPO
- ECM Libra plans to exit PN17 by year-end
- Lower net profit for AirAsia
- BToto buys RM20m REDtone shares
- Japan stocks crash on volatile bonds, weak China data; Nikkei ends down 7.3%
- MISC posts RM300m net profit in Q1, sees challenging year ahead
- KL Kepong slips to low of RM21.36 as quarterly profit drops


